2013 Catch the Wave Agenda: Friday, November 1st 7:00 a.m.

advertisement
2013 Catch the Wave Agenda: Friday, November 1 st
7:00 a.m. Registration, breakfast, viewing of poster presentations
8:00 – 9:00 a.m. Essential Guidelines for Hospital Pharmacists in Acute Coronary Syndrome
Paul P. Dobesh, PharmD, FCCP, BCPS (AQ Cardiology); Associate Professor of Pharmacy Practice,
College of Pharmacy, University of Nebraska Medical Center; Omaha, NE
Educational Objectives
Upon completion of this activity, the participant will be able to:
• Discuss current updates on treatment guidelines for ACS
• Review recent advances in treatment, technology/techniques to improve ventricular function and
relieve symptoms
• Describe the value and need for adherence to treatment guidelines and provide evidence-based
solutions to treatment with current therapies
• Examine through different case scenarios the current treatment options/techniques utilized to
address ACS
Funding: This activity is supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc. and
Lilly USA, LLC.
ACPE Credit Source: The Medical Learning Institute Inc.
9:00 – 10:00 a.m. Preparing for Biosimilars: Balancing the promise with the reality of practice
Steven D. Lucio, PharmD, BCPS; Director, Pharmacy Clinical Solutions, Novation
Educational Objectives
Upon completion of this activity, the participant will be able to:
• Explain critical principles that govern the manufacture of biologics, including biosimilars;
• Summarize key elements of the US biosimilar approval pathway;
• Describe the differences in the marketing of biosimilars as compared to generic small molecules;
• Differentiate true safety and efficacy considerations of biosimilars from commonly referenced
misperceptions.
Speaker Funding: Novation
Additional Funding: This activity is supported by an unrestricted educational grant from Hospira.
ACPE Credit Source: TG MedEd/CSHP
10:00 – 10:20 a.m. Refreshment break, poster presentations
10:20 – 11:20 a.m. Keynote Address
Transforming Pharmacy Practice: Working Together to Provide Optimal Care
Gerald E. Meyer, PharmD, MBA, FASHP; ASHP President-Elect; Director of Experiential Education,
Jefferson School of Pharmacy, Thomas Jefferson University
Educational Objectives:
At the conclusion of the presentation, the participant should be able to:
 Identify between five (5) and seven (7) obstacles confronting pharmacy in its quest to achieve its
vision of providing optimal, safe, and effective medication use to all people all of the time.
 State three (3) reasons why society would benefit from recognition of pharmacists as nonphysician providers under Section 1861 of the Social Security Act.
 Identify the four (4) inter-professional competency domains for health professional students as
developed by the Interprofessional Education Collaborative (IPEC).
 Describe at least four (4) initiatives on which ASHP can work with State Affiliates in meeting
common goals.
Speaker Funding: CSHP with support from ASHP
ACPE Credit Source: TG MedEd/CSHP
11:20 a.m. – 1:10 p.m. Exhibitors’ theatre (stamp contest) and Awards Luncheon
1:30 - 2:30 p.m. Are Your Purchasing Practices Safe?
Tips to keep counterfeit, stolen, tainted and diverted drugs from entering your supply chain
William H. Woodward, MS, RPh; Senior Director Sourcing Operations, Novation LLC
Educational Objectives
Upon completion of this activity, the participant will be able to:
• Develop a plan to prepare their organizations for the introduction of this new product category;
• Participants will be able to describe weaknesses in current drug acquisition and distribution
practices;
• Participants will be able to describe the weaknesses in current pedigree laws and regulations;
• Participants will be able to describe steps they can take at their own institutions to reduce the
likelihood of acquiring tainted, stolen, or counterfeit pharmaceutical products.
Speaker Funding: Novation
ACPE Credit Source: TG MedEd/CSHP
1:30 – 3:30 p.m. New Practitioners Leadership Development Program
Special track for Residents and PharmD students
Faculty:
Teresa Seo, PharmD, BCPS; Manager, Clinical Pharmacy Services, Yale New Haven Hospital, Saint
Raphael Campus
Nicholas Tessier, PharmD, BCPS; Clinical Pharmacy Manager, Hartford Hospital Department of
Pharmacy Services; Adjunct Assistant Clinical Professor of Pharmacy Practice, UConn School of
Pharmacy
Educational Objectives
Upon completion of this activity, the participant will be able to:
• Understand the basics of leadership versus management
• Understand the relationship between administrative, clinical and other general and specialty
leadership roles
• Understand the need for strong leaders in the future
• Learn how to build leadership qualities and engage in leadership activities as a student or new
practitioner
• Spark awareness of and interest in careers in pharmacy leadership
Speaker Funding: ASAP grant
Additional Funding: CSHP
ACPE Credit Source: TG MedEd/CSHP
2:30 – 3:30 p.m. Immune Globulin Intravenous: Product Evaluation and Formulary Considerations
Eric M. Tichy, PharmD, BCPS
Senior Clinical Pharmacy Specialist; Solid Organ Transplant; Director, PGY-2 Residency – Transplant
Yale-New Haven Hospital
Educational Objectives
Upon completion of this activity, the participant will be able to:
• Review the clinically relevant differences between Immune Globulin Intravenous (IGIV)
products;
• Describe operational considerations when converting between IVIG products;
• Compare and contrast the common adverse events associated with different IGIV projects and
strategies for mitigating these events;
• Explain the role of the pharmacist in choosing an ideal IGIV agent for hospital or health-system
formulary.
Funding: This activity is supported by an unrestricted educational grant from Baxter Healthcare
Corporation.
ACPE Credit Source: TG MedEd/CSHP
3:30 – 4:00 p.m. Dessert break, exhibit stamp contest drawing, poster presentations
4:00 - 5:00 p.m.
Legal/Regulatory Issues Update
Thomas E Buckley, RPh, MPH; Assistant Clinical Professor, UConn School of Pharmacy
Educational Objectives
Upon completion of this activity, the participant will be able to:
•
Describe the significant legislative action related to pharmacy practice in the 2013 Connecticut
General Assembly.
• Illustrate the impact of state and federal provider recognition on Connecticut pharmacy practice.
• Identify pharmacist opportunities within the Connecticut health reform innovation models.
Funding: CSHP
ACPE Credit Source: TG MedEd/CSHP
Compounding: A National Perspective
ASHP Speaker TBA
Funding: CSHP
ACPE Credit Source: TG MedEd/CSHP
5:15 – 6:30 p.m. Reverse Expo
A special opportunity for our Industry Partners, Directors of Pharmacy, CSHP Leaders
6:30 – 8:30 p.m. 65th Anniversary Celebration
Download